MSR India (508922)

Score breakdown: P/E: 0/3 · ROCE: 0/2 · Growth: 0/2 · Dividend: 0/1

Key Financials

Strengths

• Small market cap of ₹57 Cr leaves room for a meaningful re-rating if a genuine turnaround begins.
• Stock is at its 52-week high of ₹8.87, indicating some market interest or momentum.
• The aluminium, copper and zinc products industry has long-term demand from infrastructure and electrical sectors in India.
• A zero current sales base makes any true operational recovery easier to spot in future quarterly filings.

Concerns

• No current sales or meaningful profit: latest quarter shows ₹0 Cr sales and ₹-0 Cr net profit, with P/E meaningless at 0.00.
• Negative profitability indicators: ROE at -4.58% and ROCE at -5.44%.
• Profit growth has declined -107.14%, and Piotroski F-Score of 2/9 signals poor financial health.
• No book value, debt/equity, or promoter holding data disclosed, so asset backing and management alignment cannot be assessed.

AI Analysis

Every year I read a mountain of financials, and MSR India does not pass the first page. The latest quarter shows sales of ₹0 crore and profit of ₹-0 crore. Over the past year, profit growth has collapsed by over 107% while return on equity sits at -4.58% and ROCE at -5.44%. Mr. Market has nonetheless marked the stock up to ₹8.87, the top of its 52-week range, giving a market cap of ₹57 crore. That is not value investing; that is price speculation. A zero P/E and absent book value tell me there is no dependable earnings power and no balance-sheet anchor I can trust. The Piotroski F-Score of 2/9 is a distress signal—nine financial-health tests and only two pass. There is no dividend to compensate while I wait. In Buffett's language, this is a cigar butt with a soggy wrapper—and perhaps not even one smoke left. The industry, aluminium, copper and zinc, has a genuine long-term future in India's infrastructure buildout, but a company cannot benefit until it can actually sell something and earn a return above its cost of capital. If operations are being restarted, this could be a turnaround, but I need evidence: consecutive quarters of real sales, positive operating cash flow, a proper audited balance sheet, and promoter skin in the game. Until those appear, my intrinsic value column stays blank. In Graham's terms, there is no margin of safety; there is only a margin of hope. I would rather lose an opportunity than lose capital.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer